2022
DOI: 10.1136/jcp-2022-208482
|View full text |Cite
|
Sign up to set email alerts
|

Genomic landscape of colorectal carcinoma in sub-Saharan Africa

Abstract: Our understanding of the molecular classification of colorectal carcinoma (CRC) has evolved significantly over the past two decades. Tumours can be broadly categorised as microsatellite stable (MSS), microsatellite instability (MSI) or CpG island-methylator phenotype. Prognostic and predictive information is provided by these categories. The overwhelming majority of the data on which these categories are based have originated from Europe and North America. There is a dearth of information represented from Afri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…Notably, in sub-Saharan Africa, the prevalence of CRC is increasing predominantly in young individuals below the age of 40 years especially in indigenous African patients (6)(7)(8)(9). Most importantly, comprehensive cancer genetics in early age of onset (eAOO) CRC has not yet been investigated in the indigenous African population despite their increasing prevalence and greater aggressiveness than in non-African populations (10). This presents a public-health problem in cancer genetics.…”
Section: Introductionmentioning
confidence: 99%
“…Notably, in sub-Saharan Africa, the prevalence of CRC is increasing predominantly in young individuals below the age of 40 years especially in indigenous African patients (6)(7)(8)(9). Most importantly, comprehensive cancer genetics in early age of onset (eAOO) CRC has not yet been investigated in the indigenous African population despite their increasing prevalence and greater aggressiveness than in non-African populations (10). This presents a public-health problem in cancer genetics.…”
Section: Introductionmentioning
confidence: 99%